» Articles » PMID: 21288961

Prevalence of Spondyloarthritis and Its Subtypes in Southern Sweden

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2011 Feb 4
PMID 21288961
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate the prevalence of spondyloarthritis and its subtypes.

Methods: The Swedish healthcare organisation comprises a system where all inpatient and outpatient care is registered by a personal identifier. For the calendar years 2003-7, all residents aged ≥ 15 years in the southernmost county of Sweden (1.2 million inhabitants) diagnosed by a physician with spondyloarthritis (ankylosing spondylitis (AS), psoriatic arthritis (PsA), inflammatory arthritis associated with inflammatory bowel disease (Aa-IBD) or undifferentiated spondylarthritis (USpA)) were identified. To obtain valid point estimates of prevalence by the end of 2007, identification numbers were cross-referenced with the population register to exclude patients who had died or relocated.

Results: The authors estimated the prevalence of spondyloarthritis (not including chronic reactive arthritis) as 0.45% (95% CI 0.44% to 0.47%). The mean (SD) age of patients with prevalent spondyloarthritis by the end of 2007 was 53 (15) years. Among the component subtypes, PsA accounted for 54% of cases, AS 21.4%, USpA 17.8% and Aa-IBD 2.3% with a prevalence of 0.25%, 0.12%, 0.10% and 0.015%, respectively. The remaining 6.4% had some form of combination of spondyloarthritis diagnoses. The prevalence of spondyloarthritis at large was about the same in men and women. However, the subtype PsA was more prevalent in women and AS was more prevalent in men.

Conclusion: In Sweden the prevalence of spondyloarthritis leading to a doctor consultation is not much lower than rheumatoid arthritis. PsA was the most frequent subtype followed by AS and USpA, and the two most frequent subtypes PsA and AS also display some distinct sex patterns.

Citing Articles

Epidemiological trends in psoriatic arthritis: a comprehensive population-based study.

Haddad A, Elkayam P, Stein N, Feldhamer I, Cohen A, Saliba W Arthritis Res Ther. 2024; 26(1):108.

PMID: 38802958 PMC: 11129442. DOI: 10.1186/s13075-024-03339-0.


The prevalence of chronic obstructive pulmonary disease in patients with spondyloarthritis compared to the general population in the southernmost region of Sweden: a case-control study.

Zamout P, Exarchou S, Sharma A, Turesson C Clin Exp Med. 2024; 24(1):75.

PMID: 38598034 PMC: 11006728. DOI: 10.1007/s10238-024-01335-x.


The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis.

Lembke S, Macfarlane G, Jones G Rheumatology (Oxford). 2024; 63(12):3211-3220.

PMID: 38530786 PMC: 11637478. DOI: 10.1093/rheumatology/keae198.


Epidemiological analysis of patients with psoriatic arthritis in follow-up at the brazilian Unified Health System.

Rossetto C, Esther Palominos P, Machado N, Dos Santos Paiva E, Azevedo V Adv Rheumatol. 2023; 63(1):47.

PMID: 37679833 DOI: 10.1186/s42358-023-00327-x.


Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication.

Dalen J, Svedbom A, Hernlund E, Olofsson T, Black C Adv Ther. 2023; 40(10):4657-4674.

PMID: 37599341 PMC: 10499966. DOI: 10.1007/s12325-023-02600-3.